Dow Up 0.35% Nasdaq Down 0.02%

Provectus Biopharmaceuticals, Inc. (PVCT)

-NYSE MKT
0.90 0.01(1.12%) Aug 20, 4:00PM EDT
Prev Close:0.89
Open:0.93
Bid:0.84 x 4000
Ask:1.49 x 1000
1y Target Est:3.50
Beta:1.07
Next Earnings Date:N/A
Day's Range:0.89 - 0.93
52wk Range:0.30 - 6.03
Volume:241,481
Avg Vol (3m):1,433,530
Market Cap:158.97M
P/E (ttm):N/A
EPS (ttm):-0.21
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for PVCT

Comparison

Symbol% ChgMkt Cap
PVCTUp 1.12%158.97M
QLTI270.73M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :N/A
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Provectus Biopharmaceuticals, Inc., a development-stage biopharmaceutical company, is engaged in developing pharmaceuticals for oncology and dermatology indications. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback